Novartis Ag (NVSEF) Net Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Net Margin Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2025	0.00
Jun 30, 2024	0.00
Dec 31, 2023	0.00
Jun 30, 2023	0.00
Mar 31, 2023	0.00
Dec 31, 2022	0.00
Sep 30, 2022	0.00
Jun 30, 2022	0.00
Mar 31, 2022	0.00
Dec 31, 2021	0.00
Sep 30, 2021	0.00
Jun 30, 2021	0.00
Mar 31, 2021	0.00
Jun 30, 2019	-111.00
Mar 31, 2019	-146.00
Jun 30, 2018	-25.00
Mar 31, 2018	-10.00
Dec 31, 2017	-9.00
Sep 30, 2017	0.00
Jun 30, 2017	-12.00